Loading news...
Aspen Pharmacare's unbranded version of Novo Nordisk's popular diabetes drug Ozempic could be registered in Canada in the second or third quarter of this year, the South African pharmacueticals group's CEO said on Tuesday.
Aspen Pharmacare Holdings Limited (APNHY) Discusses Proposed Divestment of APAC Operations Excluding China Transcript
Aspen Pharmacare Holdings Limited (OTCPK:APNHY) Q4 2025 Earnings Call September 4, 2025 2:30 AM EDT Company Participants Sanelisiwe Tonga Stephen Saad - Group CEO & Executive Director Sean Capazorio - Group CFO & Executive Director Presentation Sanelisiwe Tonga Good morning, ladies and gentlemen. A very warm welcome to Aspen's 2025 Annual Results Presentation.
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q2 2025 Results Conference Call March 4, 2025 1:30 AM ET Company Participants Sibongakonke Nkosi - Investor Relations Stephen Saad - Group Chief Executive Officer Sean Capazorio - Group Chief Financial Officer Sibongakonke Nkosi Good morning. A very warm welcome to everyone joining us in person, online for Aspen's 2025 Interim Results Presentation.
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2024 Earnings Conference Call September 4, 2024 2:30 AM ET Company Participants Sibongakonke Nkosi - Investor Relations Stephen Saad - Group Chief Executive Officer & Executive Director Sean Capazorio - Group Chief Financial Officer & Executive Director Conference Call Participants Sibongakonke Nkosi Good morning, everyone. It's good to see you all here today and welcome to Aspen's Full Year Financial Results for the 2024 Period.
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2023 Results Conference Call August 31, 2023 2:30 AM ET Company Participants Sibongakonke N. - Investor Relations Manager Stephen Saad - Chief Executive Officer Sean Capazorio - Chief Financial Officer Conference Call Participants Christella Muligande - Bateleur Capital Charlie Le Quelenec - Ashburton Mohamed Loonat - Mianzo Asset Management Ken Osei - IFC Junaid Bray - Laurium Capital Nancy Bambo - Excelsia Capital Sibongakonke N.
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2022 Earnings Conference Call September 1, 2022 2:30 AM ET Company Participants Kuseni Dlamini - Chairman Sean Capazorio - Group Chief Financial Officer Stephen Saad - Group Chief Executive Conference Call Participants Roy Campbell - RMB Morgan Stanley Tanuja Joshi - Standard Bank Kuseni Dlamini Great, honor and privilege to stand in front of you. My name is Kuseni Dlamini.
APNHY, AHCHY, and AMK have been added to the Zacks Rank #5 (Strong Sell) List on July 11, 2022.
APNHY,BRY, and CSIQ have been added to the Zacks Rank #5 (Strong Sell) List on March 22, 2022.
Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Interim 2022 Results - Earnings Call Transcript
PRG, AGESY, and APNHY have been added to the Zacks Rank #5 (Strong Sell) List on February 28, 2022
ASPEN PHARMACR (APNHY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Q4 2021 Results - Earnings Call Transcript
ASPEN PHARMACR (APNHY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
ASPEN PHARMACR (APNHY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad Presents H1 2021 Results at JP Morgan Healthcare Conference (Transcript)
Zacks Investment Research cut shares of ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) from a strong-buy rating to a hold rating in a research note released on Thursday morning, Zacks.com reports. According to Zacks, “Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East […]